NCT02800954 2025-11-19
MCSF-MYELOME
Centre Hospitalier Universitaire, Amiens
Phase NA Completed
Clinical Trials
14 trialsNCT03508765 2024-03-08
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT05428163 2023-11-08
MYELOME-MM
Assistance Publique Hopitaux De Marseille
Completed
NCT04872023 2023-02-03
IMMUNO-MYELO
Rennes University Hospital
Phase NA Completed
NCT02627261 2022-09-06
MMRD
Hospices Civils de Lyon
Completed
NCT03956615 2021-12-01
MUM
Universitair Ziekenhuis Brussel
Phase NA Completed
NCT02716103 2021-09-10
MRD
Boston Medical Center
Completed
NCT03665155 2021-07-30
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT01916135 2020-04-27
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00569309 2018-03-12
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT01472627 2018-01-11
Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro
Dana-Farber Cancer Institute
Completed
NCT02260414 2017-05-11
METRO B
Centre Hospitalier Universitaire de Saint Etienne
Phase 2 Completed
NCT00639054 2016-01-07
MM-FISH/DNA
Rigshospitalet, Denmark
Completed
NCT01543100 2014-01-06
PACMoG
Rennes University Hospital
Phase NA Completed